Is there an economic advantage in the use of SSRIs over TCAs in the treatment of depression?

Journal of Serotonin Research

Volumn 2, Issue 4, 1996, Pages 225-235

  John, D N ^a   Wright, T ^a   Berti, C ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DOSULEPIN; FLUOXETINE; IMIPRAMINE; MIANSERIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG COST; ECONOMIC ASPECT; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PHARMACOECONOMICS; QUALITY OF LIFE; SUICIDE;

EID: 0029962163     PISSN: 13507702     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)